MyFinsight
Home
About
Contact
rna: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, RNA has $2,134,209K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
2,134,209
1,368,926
Total stockholders equity
1,886,265
1,192,664
Total liabilities and stockholders equity
2,134,209
1,368,926
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid and other
current assets
$90,181K
Marketable securities
$1,525,678K
Cash and cash
equivalents
$350,158K
Other assets
$91,042K
Right-of-use assets
$52,848K
Restricted cash
$2,798K
Property and equipment,
net
$21,504K
Total current assets
$1,966,017K
Total assets
$2,134,209K
Total liabilities and
stockholders equity
$2,134,209K
Total stockholders
equity
$1,886,265K
Total liabilities
$247,944K
Accumulated deficit
-$1,340,596K
Accumulated other
comprehensive income
$1,768K
Additional paid-in capital
$3,225,078K
Deferred revenue, net of
current portion
$32,066K
Lease liabilities,
net of current...
$45,999K
Total current
liabilities
$169,879K
Common stock, 0.0001
par value...
$15K
Deferred revenue,
current portion
$19,123K
Lease liabilities,
current portion
$3,967K
Accrued expenses and
other liabilities
$137,163K
Accounts payable
$9,626K
Subscribe for Financial Insights
Avidity Biosciences, Inc. (RNA)
Avidity Biosciences, Inc. (RNA)